[Skip to Content]

Upstate Active Clinical Trials

Study Title:

A PHASE 2B/3, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, 12 MONTH CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF MN-166 (IBUDILAST) FOLLOWED BY AN OPEN-LABEL EXTENSION IN SUBJECTS WITH AMYOTROPHIC LATERAL SCLEROSIS

Upstate Institutional Review Board (IRB) Number:

1580507

Patient Age Group:

Adults

Principal Investigator:

Jenny A Meyer

Who can I contact for more information?

Name: Sigiriya E Smolen
Phone: 315-464-9767
Email: smolens@upstate.edu

Return to Previous Page || Search Again

Top